Schiller JH - Search Results

1

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.

Chiappori AA, Kolevska T, Spigel DR, Hager S, Rarick M, Gadgeel S, Blais N, Von Pawel J, Hart L, Reck M, Bassett E, Burington B, Schiller JH. Chiappori AA, et al. Among authors: schiller jh. Ann Oncol. 2015 Feb;26(2):354-62. doi: 10.1093/annonc/mdu550. Epub 2014 Dec 2. Ann Oncol. 2015. PMID: 25467017 Free PMC article. Clinical Trial.

2

Concomitant administration of interleukin-2 plus tumor necrosis factor in advanced non-small cell lung cancer.

Schiller JH, Morgan-Ihrig C, Levitt ML. Schiller JH, et al. Am J Clin Oncol. 1995 Feb;18(1):47-51. doi: 10.1097/00000421-199502000-00010. Am J Clin Oncol. 1995. PMID: 7847259 Clinical Trial.

3

Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival.

Schiller JH, Storer B, Berlin J, Wittenkeller J, Larson M, Pharo L, Larson M, Berry W. Schiller JH, et al. J Clin Oncol. 1996 Jun;14(6):1913-21. doi: 10.1200/JCO.1996.14.6.1913. J Clin Oncol. 1996. PMID: 8656260 Clinical Trial.

4

Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial.

Tannehill SP, Mehta MP, Larson M, Storer B, Pellet J, Kinsella TJ, Schiller JH. Tannehill SP, et al. Among authors: schiller jh. J Clin Oncol. 1997 Aug;15(8):2850-7. doi: 10.1200/JCO.1997.15.8.2850. J Clin Oncol. 1997. PMID: 9256128 Clinical Trial.

5

Lung cancer: review of the ECOG experience. Eastern Cooperative Oncology Group.

Schiller JH, Cleary J, Johnson D. Schiller JH, et al. Oncology. 1997 Sep-Oct;54(5):353-62. doi: 10.1159/000227718. Oncology. 1997. PMID: 9260595 Review.

6

An update on North American randomized studies in non-small cell lung cancer.

Bunn PA Jr, Vokes EE, Langer CJ, Schiller JH. Bunn PA Jr, et al. Among authors: schiller jh. Semin Oncol. 1998 Aug;25(4 Suppl 9):2-10. Semin Oncol. 1998. PMID: 9728578 Review.

7

Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer.

von Pawel J, Schiller JH, Shepherd FA, Fields SZ, Kleisbauer JP, Chrysson NG, Stewart DJ, Clark PI, Palmer MC, Depierre A, Carmichael J, Krebs JB, Ross G, Lane SR, Gralla R. von Pawel J, et al. Among authors: schiller jh. J Clin Oncol. 1999 Feb;17(2):658-67. doi: 10.1200/JCO.1999.17.2.658. J Clin Oncol. 1999. PMID: 10080612 Clinical Trial.

8

Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma.

Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, Krook J, Harrington D, Johnson DH. Sweeney CJ, et al. Cancer. 2001 Nov 15;92(10):2639-47. doi: 10.1002/1097-0142(20011115)92:10<2639::aid-cncr1617>3.0.co;2-8. Cancer. 2001. PMID: 11745199 Clinical Trial.

9

Novel therapies for lung cancer.

Hoang T, Traynor AM, Schiller JH. Hoang T, et al. Among authors: schiller jh. Surg Oncol. 2002 Dec;11(4):229-41. doi: 10.1016/s0960-7404(02)00056-7. Surg Oncol. 2002. PMID: 12450559 Review.

10

A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

Herbst RS, Hammond LA, Carbone DP, Tran HT, Holroyd KJ, Desai A, Williams JI, Bekele BN, Hait H, Allgood V, Solomon S, Schiller JH. Herbst RS, et al. Among authors: schiller jh. Clin Cancer Res. 2003 Sep 15;9(11):4108-15. Clin Cancer Res. 2003. PMID: 14519633 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters